Brought to you by 
Cadence gets option to buy Incline Therapeutics; terminated
09 May 2023
Executive Summary
Cadence Pharmaceuticals Inc. has agreed to invest $3.5mm in fellow hospital-focused pharma company Incline Therapeutics Inc. for the exclusive option to acquire the company in the next few years for an amount that will not exceed $135mm.
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Equity
- Includes M&A Option
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cadence gets option to buy Incline Therapeutics; terminated
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice